OTC antiseptic product firms are making the most of a recent FDA rulemaking that removes 24 ingredients from approval for use under a monograph by focusing on six substances that remain available but face potential exclusion.
A final rule FDA published in December 2017 applies only the generally regarded as safe and effective (GRASE) status...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?